Cyclohexyl beta-hydroxy alkyl amines and medical uses thereof
US-2024390298-A1 · Nov 28, 2024 · US
Therapeutic uses of beta-3 adrenergic receptor agonist derivatives in particular to modulate apoptosis
US9161925B2 · US · B2
| Field | Value |
|---|---|
| Publication number | US-9161925-B2 |
| Application number | US-65231710-A |
| Country | US |
| Kind code | B2 |
| Filing date | Jan 5, 2010 |
| Priority date | Jul 5, 2007 |
| Publication date | Oct 20, 2015 |
| Grant date | Oct 20, 2015 |
How to read this patent
A practical reading order for non-experts. Skip the full description unless you need deep technical detail.
- Title
What the patent document calls the invention.
- Abstract
A short plain-language summary of the technical disclosure.
- Assignees and inventors
Who owns or filed the patent and who is credited as inventor.
- Key dates
Filing, priority, publication, and grant dates set the timeline.
- First independent claim
The legal scope of protection — read this for what is actually claimed.
- CPC / IPC classifications
Technology tags used to group this patent with similar filings.
- Citations and related patents
Prior art links and similar publications in this corpus.
Abstract
Official abstract text for this publication.
The present invention relates to the new therapeutic uses of beta-3 adrenergic receptor agonist derivatives in particular to inhibit apoptosis and treat and/or prevent apoptosis-related diseases and disorders.
First claim
Opening claim text (preview).
The invention claimed is: 1. A method of reducing the risk of pre-term labor in a pregnant female patient having increased uterine apoptosis comprising: (a) determining that said pregnant female patient has increased uterine apoptosis, said risk of pre-term labor in the pregnant female patient being increased as a result of said increased uterine apoptosis; and (b) administering to said pregnant female patient having increased uterine apoptosis a therapeutically effective amount…
Assignees
Inventors
Classifications
Patent family
Related publications grouped by family.
External sources
Next steps
Free tools are coming soon. Tell us what you want to track and we'll notify you.
Frequently asked questions
Answers are generated from the same data shown on this page.
- What does patent US9161925B2 cover?
- The present invention relates to the new therapeutic uses of beta-3 adrenergic receptor agonist derivatives in particular to inhibit apoptosis and treat and/or prevent apoptosis-related diseases and disorders.
- Who is the assignee on this patent?
- Bardou Marc, Sanofi Sa
- What technology area does this patent fall under?
- Primary CPC classification A61K31/18. Mapped technology areas include Human Necessities.
- When was this patent published?
- Publication date Tue Oct 20 2015 00:00:00 GMT+0000 (Coordinated Universal Time) (B2). Legal status and post-grant events are not shown on this page.
- What related patents are in patentsdb?
- We list 8 related publications on this page (citations in our corpus or others sharing the same primary CPC).